Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Claudia A Simões-Pires"'
Autor:
Netha Ulahannan, Ronald Cutler, Reanna Doña-Termine, Claudia A Simões-Pires, N Ari Wijetunga, Matthew McKnight Croken, Andrew D Johnston, Yu Kong, Shahina B Maqbool, Masako Suzuki, John M Greally
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0275226 (2022)
To gain insights into the molecular interactions of an intracellular pathogen and its host cell, we studied the gene expression and chromatin states of human fibroblasts infected with the Apicomplexan parasite Toxoplasma gondii. We show a striking ac
Externí odkaz:
https://doaj.org/article/af22b0789185460b95069884872c8950
Autor:
Andrew D. Johnston, Claudia A. Simões-Pires, Taylor V. Thompson, Masako Suzuki, John M. Greally
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-16 (2019)
Functional variants have been proposed to alter transcription factor binding. Here, the authors provide direct evidence that functional variants within the TBC1D4 gene, encoding an NFκB binding site, can alter transcription factor binding, and use C
Externí odkaz:
https://doaj.org/article/88d29a982eee4fd9b508af61899db295
Autor:
Mohamed D. M. Traoré, Vincent Zwick, Claudia A. Simões-Pires, Alessandra Nurisso, Mark Issa, Muriel Cuendet, Marjorie Maynadier, Sharon Wein, Henri Vial, Helene Jamet, Yung-Sing Wong
Publikováno v:
ACS Omega, Vol 2, Iss 4, Pp 1550-1562 (2017)
Externí odkaz:
https://doaj.org/article/ee61c804c38643ec997c1930494af5e4
Publikováno v:
Encyclopedia of Analytical Chemistry
Autor:
Alali Abdulrazak, Andrew D. Johnston, Shahina Maqbool, Masako Suzuki, Claudia A. Simões-Pires, Hanae Sato, John M. Greally
Publikováno v:
The CRISPR journal. 3(3)
The CRISPR/Cas9 system can be modified to perform ‘epigenetic editing’ by utilizing the catalytically-inactive (dead) Cas9 (dCas9) to recruit regulatory proteins to specific genomic locations. In prior studies, epigenetic editing with multimers o
Autor:
Esther R. Berko, David Kronn, Adam Auton, John M. Greally, Masako Suzuki, Kenny Ye, Anthony Marcketta, Yu Kong, Shahina Maqbool, Claudia A. Simões-Pires
Publikováno v:
Genome Research. 28:1039-1052
Current approaches to detect and characterize mosaic chromosomal aneuploidy are limited by sensitivity, efficiency, cost, or the need to culture cells. We describe the mosaic aneuploidy detection by massively parallel sequencing (MAD-seq) capture ass
Autor:
Claudia A. Simões-Pires, Yung-Sing Wong, Mohamed Dit Mady Traoré, Vincent Zwick, Sharon Wein, Muriel Cuendet, Marjorie Maynadier, Mark E. Issa, Alessandra Nurisso, Henri Vial, Hélène Jamet
Publikováno v:
ACSOmega
ACS Omega
ACS Omega, Vol. 2, No 4 (2017) pp. 1550-1562
ACS Omega, Vol 2, Iss 4, Pp 1550-1562 (2017)
ACS Omega, ACS Publications, 2017, 2 (4), pp.1550-1562. ⟨10.1021/acsomega.6b00481⟩
ACS Omega
ACS Omega, Vol. 2, No 4 (2017) pp. 1550-1562
ACS Omega, Vol 2, Iss 4, Pp 1550-1562 (2017)
ACS Omega, ACS Publications, 2017, 2 (4), pp.1550-1562. ⟨10.1021/acsomega.6b00481⟩
Little is known about the biological and structural features that govern the isoform selectivity for class I histone deacetylases (HDACs) over HDAC6. In addition to that for known inhibitors, like benzamides, psammaplin A, and cyclodepsipeptide-deriv
Publikováno v:
Planta Medica. 81:S1-S381
Autor:
Laurence Marcourt, Vincent Zwick, Pierre-Marie Allard, Katia Gindro, Lucie Ory, Jean-Luc Wolfender, Claudia A. Simões-Pires, Muriel Cuendet
Publikováno v:
Phytochemical Analysis. 28:93-100
Introduction Histone deacetylases (HDAC) are considered as promising targets for cancer treatment. Today, four HDAC inhibitors, vorinostat, romidepsin, belinostat, and panobinostat, have been approved by the Food and Drug Administration (FDA) for can
Publikováno v:
Communications Biology
Communications Biology, Vol 2, Iss 1, Pp 1-6 (2019)
Communications Biology, Vol 2, Iss 1, Pp 1-6 (2019)
While human lymphoblastoid cell lines represent a valuable resource for population genetic studies, they have usually been regarded as difficult for CRISPR-mediated genomic editing because of very inefficient DNA transfection and retroviral or lentiv